About this episode

The episode discusses buy-and-bill drugs in urology, focusing on ZUSDURI® and the associated challenges for practices.

June 26, 2026 In this episode, Scott, Mark, and Dr. Ray Painter continue their discussion on buy-and-bill drugs, using ZUSDURI® as a case study to explore the clinical, operational, and reimbursement challenges facing urology practices. The conversation covers prior authorizations, payer eligibility checks, documentation requirements, medical record reviews, RAC audits, and strategies for successfully introducing new drug therapies into a practice. The team also discusses the importance of ...

Topics covered

• buy-and-bill drugs
• urology practices
• reimbursement challenges
• prior authorizations
• payer eligibility
• new drug therapies

Keywords

• buy-and-bill
• urology
• reimbursement
• ZUSDURI
• prior authorization
• medical records
• RAC audits

More episodes of Urology Coding and Reimbursement Podcast

• UCR 296: 2027 Medicare Proposed Rule – The Changes That Matter Most to Urology · July 17, 2026 · 37 min
• UCR 295: New Kidney Stone Scope and Sheath Facility Payments – What Every Urologist Needs to Know · July 10, 2026 · 40 min
• UCR 293: Unprocessable Claims, Timely Filing Denials, and Urodynamics Global Billing · June 20, 2026 · 27 min

Explore listener stats, chart rankings, contacts and more on the Urology Coding and Reimbursement Podcast podcast page.